Status: Not yet recruiting

A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

A multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standard of sare versus standard of sare slone in the management of post-mohs micrographic surgery defects.

Participants needed: 160

Trial details

Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: BioLab HoldingsUpdated: Jul 10, 2026

Eligibility criteria

The potential subject must be at least 18 years of age or older. [+8]

The potential subject must agree to attend the weekly study visits required by t... [+8]

Status: Recruiting

A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.

The study is a multicenter, prospective, controlled modified multi-platform trial assessing the efficacy of human placental membrane products and standard of care in the management of nonhealing diabetic foot ulcers and venous leg ulcers.

Participants needed: 50

Trial details

Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: BioLab HoldingsUpdated: Feb 9, 2026Locations: 1

Eligibility criteria

The potential subject must be at least 18 years of age or older. [+6]

The potential subject is known to have a life expectancy of < 6 months. [+19]

Status: Recruiting

Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

The purpose of this study is to evaluate the efficacy of human placental membrane products and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers.

Participants needed: 650

Trial details

Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: BioLab HoldingsUpdated: Jul 28, 2025Locations: 1

Eligibility criteria

The potential subject must be at least 18 years of age or older. [+10]

The potential subject must consent to using the prescribed offloading method for... [+47]

Clinical trials

A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.

Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers